Ninoschka C. D'souza
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
One Week Exposure to a Somatostatin Receptor 2 Antagonist (SSTR2a) Enhances Glucagon Counterregulation to Insulin-Induced Hypoglycaemia and Does Not Worsen Glycemia in a Male Rat Model of Insulin-Requiring Type 2 Diabetes.
Journal: Diabetes, obesity & metabolism
Published: January 12, 2026
Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes.
Journal: Frontiers in pharmacology
Published: September 25, 2023
Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes.
Journal: Frontiers in pharmacology
Published: September 16, 2023
The Impact of Sex, Body Mass Index, Age, Exercise Type and Exercise Duration on Interstitial Glucose Levels during Exercise.
Journal: Sensors (Basel, Switzerland)
Published: September 01, 2023
Effects of somatostatin receptor type 2 antagonism during insulin-induced hypoglycaemia in male rats with prediabetes.
Journal: Diabetes, obesity & metabolism
Published: October 05, 2022
ZT-01: A novel somatostatin receptor 2 antagonist for restoring the glucagon response to hypoglycaemia in type 1 diabetes.
Journal: Diabetes, obesity & metabolism
Published: October 15, 2021
Carbohydrate Requirements for Prolonged, Fasted Exercise With and Without Basal Rate Reductions in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
Journal: Diabetes care
Published: June 23, 2020
p107 Determines a Metabolic Checkpoint Required for Adipocyte Lineage Fates.
Journal: Stem cells (Dayton, Ohio)
Published: August 22, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026